PharmacoEconomics (2017) 35:793–804 DOI 10.1007/s40273-017-0511-7 SYSTEMATIC REVIEW Does the Public Prefer Health Gain for Cancer Patients? A Systematic Review of Public Views on Cancer and its Characteristics 1 2,3 4 1 • • • Liz Morrell Sarah Wordsworth Sian Rees Richard Barker Published online: 29 April 2017 The Author(s) 2017. This article is an open access publication Abstract while the other found no such preference but provided Background Policies such as the Cancer Drugs Fund in results consistent with population health maximisation. England assumed a societal preference to fund cancer care Other studies mostly showed support for cancer but did not relative to other conditions, even if that resulted in lower require a direct health trade-off. Severity and end-of-life health gain for the population overall. searches identiﬁed 12 and 6 papers, respectively, which Objective The aim of this study was to investigate the were additional to existing reviews. There is consistent evidence for such a preference among the UK public. evidence that people give priority to severe illness, while Methods The MEDLINE, PubMed and Econlit electronic results for end-of-life are mixed. databases were searched for studies relating to preferences Conclusion We did not ﬁnd consistent support for a pref-
PharmacoEconomics – Springer Journals
Published: Apr 29, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera